Miro, Elvie Jane I.
HRN: 03-25-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2023
CEFUROXIME 1.5GM (VIAL)
04/08/2023
04/10/2023
IVT
1.5g
Q8H
S/P Primary LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes